XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income (loss) $ 44,296 $ 28,217 $ (68,445)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 164,259 178,946 193,138
Long-lived and other asset impairment 21,442 21,397 79,556
Goodwill impairment     99,830
Unrealized change in fair value of investment in unconsolidated affiliate 1,864    
Inventory write-downs 1,640 997 1,349
Amortization of operating lease ROU asset 3,206 3,880 3,477
Amortization of debt issuance costs 5,152 10,127 5,554
Amortization of debt discount     187
Amortization of debt premium (2,006) (2,006) (84)
Amortization of capitalized implementation costs 1,984    
Amortization of dedesignated interest rate swap 410 863  
Debt extinguishment loss     3,971
Interest rate swaps 631 3,539 3,178
Stock-based compensation expense 11,928 11,336 10,551
Non-cash restructuring charges     1,660
Provision for (benefit) from credit losses 206 (90) 3,525
(Gain) loss on sale of assets, net (12,396) (11,313) 1,832
Gain on sale of business (28,098) (18,945) (12,475)
Deferred income tax provision (benefit) 15,229 10,379 (17,764)
Amortization of contract costs 19,162 19,990 26,629
Deferred revenue recognized in earnings (20,956) (10,382) (19,489)
Changes in operating assets and liabilities:      
Accounts receivable, net (19,971) 4,445 36,395
Inventory (10,520) (12,989) 3,972
Other assets (2,653) 635 (5,797)
Contract costs (29,575) (16,991) (13,262)
Accounts payable and other liabilities 13,529 5,269 (15,089)
Deferred revenue 24,642 10,217 12,732
Other 45 (121) 147
Net cash provided by operating activities 203,450 237,400 335,278
Cash flows from investing activities:      
Capital expenditures (239,867) (97,885) (140,302)
Proceeds from sale of business 20,654 29,562 18,911
Proceeds from sale of property, equipment and other assets 99,611 83,345 33,651
Proceeds from insurance and other settlements 3,353 1,085 2,709
Investments in unconsolidated entities (14,667)    
Net cash (used in) provided by investing activities (130,916) 16,107 (85,031)
Cash flows from financing activities:      
Borrowings of long-term debt 826,733 704,751 1,049,000
Repayments of long-term debt (809,983) (863,251) (1,204,375)
Payments of debt issuance costs   (2,451) (5,269)
Payments for settlement of interest rate swaps that include financing elements (1,334) (4,390) (2,916)
Dividends paid to stockholders (90,315) (89,343) (88,832)
Net proceeds from issuance of common stock 4,176 3,401  
Proceeds from stock issued under ESPP 633 713 683
Purchases of treasury stock (2,447) (2,465) (1,804)
Contribution from Exterran Corporation     678
Net cash used in financing activities (72,537) (253,035) (252,835)
Net increase (decrease) in cash and cash equivalents (3) 472 (2,588)
Cash and cash equivalents, beginning of period 1,569 1,097 3,685
Cash and cash equivalents, end of period 1,566 1,569 1,097
Supplemental disclosure of cash flow information:      
Interest paid 98,406 100,002 99,797
Income taxes refunded (paid), net (407) (247) (94)
Supplemental disclosure of non-cash investing and financing transactions:      
Accrued capital expenditures $ 9,899 $ 7,641 1,624
Non-cash consideration received in sales of a business     $ 5,762